U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. directed the U.S. Food and Drug Administration (FDA) to explore potential rulemaking opportunities to tighten or ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

The Senate Health, Education, Labor, & Pensions (HELP) Committee voted Thursday to recommend that the Senate confirm ...

The agency’s approach to GRAS determinations has evolved over the intervening decades, with the last major change coming in 2016 with the publication of what is referred to as the final GRAS rule.

Cannabidiol (CBD) is increasingly recognized for its role as an antiseizure medication, especially for the management of Drug-Resistant Epilepsy (DRE). This ...

The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...

The Senate Committee on Health, Labor and Pensions voted Thursday to approve Marty Makary as commissioner of the Food and Drug Administration. He will likely be confirmed in the full Senate.

Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.

Activists have slammed the GRAS program, arguing it allows companies to “self-certify” the safety of food additives.

President Donald Trump's nominee to lead the Food and Drug Administration (FDA), Dr. Marty Makary, passed a key committee vote on Thursday morning.